ViCentra

Kaleido, operating under the website hellokaleido.com, is a healthcare startup that provides innovative solutions for individuals living with diabetes. The company's primary product is a compact, wearable insulin pump that offers flexibility and convenience to its users. The pump is designed to hold 200 units of rapid-acting insulin, with a battery life of three days, and can be worn underwater for up to an hour.

Kaleido's target market is individuals with diabetes who require insulin therapy. The company operates in the healthcare sector, specifically within the diabetes management market. The business model is centered around providing a product that offers a more convenient and flexible alternative to traditional insulin pumps.

Kaleido makes money by selling its insulin pumps to patients. The pumps are prescribed by healthcare professionals who believe insulin pump therapy is a suitable treatment option for their patients. The company's unique selling proposition is its micro pulse technology, which ensures consistent insulin delivery, and its easy-to-apply infusion sets, which are designed to make the process of using the pump as straightforward as possible.

In summary, Kaleido is a healthcare startup that offers an innovative, user-friendly solution for individuals requiring insulin therapy. Its product is designed to make living with diabetes more manageable, providing users with the freedom and flexibility to live their lives without the constraints of traditional insulin pumps.

Keywords: Healthcare, Diabetes Management, Insulin Pump, Wearable Technology, User-Friendly, Flexibility, Convenience, Micro Pulse Technology, Infusion Sets, Prescription-Based.